NetworkNewsBreaks — SOBR Safe Inc. (NASDAQ: SOBR
Post# of 112
SOBRSafe (NASDAQ: SOBR), providers of next-generation transdermal alcohol detection solutions, has entered into an international channel partnership to begin sales in Australia and New Zealand for its SOBRsure(TM) platform. The partnership is with Drug Testing Business Success, the region’s leading drug- and alcohol-testing service provider. According to the announcement, Drug Testing Business Success has impressive experience in the transdermal alcohol detection industry and plans to distribute SOBRsure through a coalition of suppliers and a dedicated e-commerce website focusing on the behavioral health and justice sectors. The partnership included a 90-day proof-of-concept period; SOBRsure is now available for sale and is in active client use. “We believe we are gaining momentum and demonstrating traction in the behavior health and justice markets here in the U.S., and this most recent agreement with our newest channel partner is a meaningful validation of our technology and approach,” said SOBRsafe chair and CEO Dave Gandini in the press release. “We’re excited about this new revenue stream in Australia and New Zealand, and we believe that this could accelerate broader global expansion.”
NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at http://nnw.fm/SOBR
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer